CAMERON DELFORGE: Open Payments
NPI 1720600448 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 45 payments from 17 companies in 2025. Trend: 2023 $826 · 2024 $1,204 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $211 |
| AstraZeneca Pharmaceuticals LP | 8 | $155 |
| Amgen Inc. | 3 | $59 |
| PFIZER INC. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| ABBVIE INC. | 2 | $35 |
| ViiV Healthcare Company | 2 | $30 |
| Exact Sciences Corporation | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: AIRSUPRA, Wegovy, Ozempic, FARXIGA, TRINTELLIX, KRYSTEXXA, SPRAVATO, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
